- Home
- BWXT vs ITCI Comparison
BWXT vs ITCI Comparison
Compare BWXT & ITCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BWXT
- ITCI
- Stock Information
- Founded
- BWXT 1867
- ITCI 2002
- Country
- BWXT United States
- ITCI United States
- Employees
- BWXT N/A
- ITCI N/A
- Industry
- BWXT
- ITCI Biotechnology: Pharmaceutical Preparations
- Sector
- BWXT
- ITCI Health Care
- Exchange
- BWXT Nasdaq
- ITCI Nasdaq
- Market Cap
- BWXT 8.9B
- ITCI 8.0B
- IPO Year
- BWXT N/A
- ITCI N/A
- Fundamental
- Price
- BWXT $98.43
- ITCI $75.22
- Analyst Decision
- BWXT Buy
- ITCI Strong Buy
- Analyst Count
- BWXT 8
- ITCI 11
- Target Price
- BWXT $102.57
- ITCI $93.55
- AVG Volume (30 Days)
- BWXT 387.0K
- ITCI 462.3K
- Earning Date
- BWXT 10-30-2024
- ITCI 10-31-2024
- Dividend Yield
- BWXT 0.98%
- ITCI N/A
- EPS Growth
- BWXT 19.66
- ITCI N/A
- EPS
- BWXT 2.92
- ITCI N/A
- Revenue
- BWXT $2,600,935,000.00
- ITCI $564,526,000.00
- Revenue This Year
- BWXT $8.08
- ITCI $46.60
- Revenue Next Year
- BWXT $4.71
- ITCI $37.06
- P/E Ratio
- BWXT $33.67
- ITCI N/A
- Revenue Growth
- BWXT 11.69
- ITCI 54.31
- 52 Week Low
- BWXT $72.14
- ITCI $45.50
- 52 Week High
- BWXT $107.18
- ITCI $84.89
- Technical
- Relative Strength Index (RSI)
- BWXT 50.02
- ITCI 53.93
- Support Level
- BWXT $94.07
- ITCI $73.05
- Resistance Level
- BWXT $97.08
- ITCI $76.34
- Average True Range (ATR)
- BWXT 2.03
- ITCI 1.67
- MACD
- BWXT -0.47
- ITCI 0.19
- Stochastic Oscillator
- BWXT 42.54
- ITCI 75.60
About BWXT BWX Technologies Inc.
BWX Technologies Inc is a specialty manufacturer & service provider of nuclear components. It operates in two segments. The government Operations segment consists of legacy Nuclear Operations Group & Nuclear Services Group segments with certain research & development activities in the areas of advanced reactors & advanced manufacturing. The commercial Operations segment consists of the legacy Nuclear Power Group segment with certain research and development & commercialization activities in the areas of medical & industrial radioisotopes & radiopharmaceuticals. The majority is from the Government Operations segment. Geographically, it operates in the United States, Canada & United Kingdom, out of which the majority is from the United States.
About ITCI Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.